Target intelligence / Profile preview

Glycogen synthase 1 (muscle) (GYS1)

Target
GYS1
Molecular classification
Enzyme, Glycosyltransferase (retaining, GT3 superfamily)
01

Overview

Glycogen synthase 1 is the principal enzyme responsible for synthesizing glycogen in skeletal and cardiac muscle, catalyzing the addition of glucose units to form a polysaccharide chain using UDP-glucose as the substrate. It is tightly regulated by phosphorylation and dephosphorylation as well as allosteric effectors such as glucose-6-phosphate, forming the central rate-limiting step of glycogen biosynthesis. Dysregulation of GYS1 activity underlies several disease processes including glycogen storage disease type 0, certain neurodegenerative diseases, and is involved in cancer progression by altering energy metabolism. Variants and abnormal regulation of GYS1 can lead to profound clinical symptoms, especially following exertion or metabolic stress.

Other names
Glycogen [starch] synthase, muscleGlycogen synthase 1 (muscle)GSYGYSGYS1_HUMANMuscle glycogen synthase
02

Mechanism of action

Modulation of enzymatic activity (inhibition or activation). Altering post-translational modifications (phosphorylation/dephosphorylation). Regulation of interacting protein partners (e.g., PP1 regulatory subunits, PTG).

03

Biological functions

Glycogen biosynthesisEnergy storage in muscle tissueRegulation of muscle and cardiac energy metabolism
04

Disease associations

Glycogen storage disease type 0 (cardiac and skeletal forms)Pompe disease and other glycogen storage disordersNeurodegenerative disease (malto-oligoglucan-associated)Cancer (notably clear cell renal carcinoma and myeloid leukemia)
05

Safety considerations

Risk of hypoglycemia, muscle weakness, and cardiac arrhythmias if glycogen synthesis is impaired or excessively blockedMetabolic side effects due to altered glucose handlingCardiac arrest and sudden death in severe deficiency states
06

Interacting drugs

No approved drugs directly targeting GYS1 as of the latest search, but research focuses on modulating its activity for glycogenosis, metabolic, and oncologic indications. Indirect interaction with metabolic modulators is possible.
07

Biomarkers

GYS1 expression in muscle biopsy (diagnosis of glycogen storage disorders)GYS1 phosphorylation state (marker of enzymatic activation/inhibition)

Beyond the preview

Go deeper on Glycogen synthase 1 (muscle) (GYS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycogen synthase 1 (muscle) (GYS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call